Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 88

Results For "NDA"

5509 News Found

Motorica India CRE programme enhances clinician training and patient-centric prosthetic care
Healthcare | April 23, 2026

Motorica India CRE programme enhances clinician training and patient-centric prosthetic care

Three-day programme focuses on advanced socket design, myoelectric technology and clinical skill development


India’s nutraceutical market sees entry of quantum-enhanced curcumin formulation
News | April 23, 2026

India’s nutraceutical market sees entry of quantum-enhanced curcumin formulation

New formulation by Greenspace Herbs to target improved efficacy and lower dosage in curcumin supplements


PAGE, 8chili Inc. collaborate to scale AI-powered pharma training ecosystem
Digitisation | April 23, 2026

PAGE, 8chili Inc. collaborate to scale AI-powered pharma training ecosystem

Platform integrates VR simulations and AI-driven coaching to build job-ready skills in pharma manufacturing


Cipla’s generic Ventolin HFA secures USFDA approval
Drug Approval | April 23, 2026

Cipla’s generic Ventolin HFA secures USFDA approval

Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market


Experts convene in India to push for urgent action on dengue treatment gaps
Public Health | April 23, 2026

Experts convene in India to push for urgent action on dengue treatment gaps

Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches


Japanese pharma firms turn to CDMOs early as peptide complexity rises
News | April 23, 2026

Japanese pharma firms turn to CDMOs early as peptide complexity rises

Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages


Lupin launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in USA
Drug Approval | April 23, 2026

Lupin launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in USA

The product is approved as bioequivalent to Xigduo XR for the indications outlined in the reference drug’s labelling


Pfizer unleashes wave of breakthrough cancer data at ASCO 2026
R&D | April 22, 2026

Pfizer unleashes wave of breakthrough cancer data at ASCO 2026

Pharma giant targets new standards of care


Moderna wins EU approval for first combined flu & COVID shot for adults 50+
Drug Approval | April 22, 2026

Moderna wins EU approval for first combined flu & COVID shot for adults 50+

The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states


Crown Bioscience partners with Turbine to accelerate translational oncology research
R&D | April 22, 2026

Crown Bioscience partners with Turbine to accelerate translational oncology research

The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems